{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:08:18Z","timestamp":1789520898399,"version":"build-2803163510"},"reference-count":166,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100024521","name":"Oklahoma Tobacco Settlement Endowment Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA297076"],"award-info":[{"award-number":["R01CA297076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG070915"],"award-info":[{"award-number":["R01AG070915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189672","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:25:47Z","timestamp":1785799547000},"page":"189672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rewiring the tumor microenvironment: IGFBP2 at the Nexus of remodeling and therapy resistance?"],"prefix":"10.1016","volume":"1881","author":[{"given":"Provas","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Martha","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta","family":"Panja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resham","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189672_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217454","article-title":"Interrogation of the tumor microenvironment by nanoparticles","volume":"612","author":"Panja","year":"2025","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12032-025-02641-4","article-title":"Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies","volume":"42","author":"Shah","year":"2025","journal-title":"Med. Oncol."},{"issue":"31","key":"10.1016\/j.bbcan.2026.189672_bb0025","article-title":"Gold nanoparticles disrupt the IGFBP2\/mTOR\/PTEN axis to inhibit ovarian cancer growth","volume":"9","author":"Hossen","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189672_bb0030","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/s41388-020-1154-2","article-title":"IGFBP2: integrative hub of developmental and oncogenic signaling network","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"issue":"28","key":"10.1016\/j.bbcan.2026.189672_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1840","article-title":"IGFBP2 secretion by mammary adipocytes limits breast cancer invasion","volume":"9","author":"Conway","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189672_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.canlet.2020.02.036","article-title":"IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma","volume":"477","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0045","first-page":"1981","article-title":"Gene expression and prognosis of insulin-like growth factor-binding protein family members in non-small cell lung cancer","volume":"42","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189672_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046851","article-title":"Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0055","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1038\/s41598-017-12191-z","article-title":"Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma","volume":"7","author":"Katayama","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0060","first-page":"341","article-title":"Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential","volume":"13","author":"Miyake","year":"2005","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189672_bb0065","first-page":"6284","article-title":"Novel serum markers HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer","volume":"18","author":"Vocka","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0070","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0002-9440(10)64437-9","article-title":"Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation","volume":"161","author":"Allander","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0075","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","article-title":"Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease","volume":"106","author":"Stanley","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3892\/or.2020.7892","article-title":"IGFBP2 in cancer: Pathological role and clinical significance (Review)","volume":"45","author":"Wei","year":"2021","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0085","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/me.2004-0392","article-title":"Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos","volume":"19","author":"Wood","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003926","article-title":"Duplication of the IGFBP-2 gene in teleost fish: protein structure and functionality conservation and gene expression divergence","volume":"3","author":"Zhou","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189672_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2026.189672_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101245","article-title":"Insulin-like growth factors: ligands, binding proteins, and receptors","volume":"52","author":"LeRoith","year":"2021","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/endrev\/bnad008","article-title":"Signaling pathways of the insulin-like growth factor binding proteins","volume":"44","author":"Baxter","year":"2023","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12079-015-0261-2","article-title":"IGFBP-2 - taking the lead in growth, metabolism and cancer","volume":"9","author":"Yau","year":"2015","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0115","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/en.2007-0959","article-title":"A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import","volume":"149","author":"Iosef","year":"2008","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0120","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/onc.2012.630","article-title":"IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells","volume":"33","author":"Azar","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0125","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/JME-13-0184","article-title":"Heparin-binding mechanism of the IGF2\/IGF-binding protein 2 complex","volume":"52","author":"Lund","year":"2014","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189672_bb0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003301","article-title":"Masters of adaptation: how cancer and immune cell plasticity mediates tumor progression","volume":"23","author":"Rosenbaum","year":"2025","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0150","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189672_bb0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","article-title":"The role of mechanical forces in tumor growth and therapy","volume":"16","author":"Jain","year":"2014","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189672_bb0160","doi-asserted-by":"crossref","first-page":"1026898","DOI":"10.3389\/fimmu.2022.1026898","article-title":"Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6230","key":"10.1016\/j.bbcan.2026.189672_bb0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-4-38","article-title":"Collagen reorganization at the tumor-stromal interface facilitates local invasion","volume":"4","author":"Provenzano","year":"2006","journal-title":"BMC Med."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189672_bb0175","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.15252\/embj.201694912","article-title":"Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium","volume":"36","author":"Reid","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2026.189672_bb0180","doi-asserted-by":"crossref","first-page":"175694","DOI":"10.1016\/j.ejphar.2023.175694","article-title":"Dual roles of FAK in tumor angiogenesis: a review focused on pericyte FAK","volume":"947","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189672_bb0185","doi-asserted-by":"crossref","first-page":"1274209","DOI":"10.3389\/fphar.2024.1274209","article-title":"Roles and inhibitors of FAK in cancer: current advances and future directions","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071164","article-title":"Interleukin-6 at the host-tumor interface: STAT3 in biomolecular condensates in cancer cells","volume":"11","author":"Sehgal","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189672_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114112","article-title":"Engineering interferons and interleukins for cancer immunotherapy","volume":"182","author":"Holder","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0205","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0210","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12967-025-06791-x","article-title":"Hidden forces: the impact of cancer-associated fibroblasts on non-small cell lung cancer development and therapy","volume":"23","author":"Wu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0215","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3390\/jpm12122005","article-title":"IGFBP2 drives Regulatory T cell differentiation through STAT3\/IDO signaling pathway in pancreatic cancer","volume":"12","author":"Sun","year":"2022","journal-title":"J. Personalized Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.gendis.2014.10.004","article-title":"Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance","volume":"2","author":"Denduluri","year":"2015","journal-title":"Genes Dis"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189672_bb0225","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.1120375109","article-title":"Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-\u03baB network","volume":"109","author":"Holmes","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0230","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/bjc.2014.435","article-title":"Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin \u03b21-ERK pathway","volume":"111","author":"Han","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189672_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184182","article-title":"IGFBP2 enhances adipogenic differentiation potentials of mesenchymal stem cells from Wharton's jelly of the umbilical cord via JNK and Akt signaling pathways","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.bbcan.2026.189672_bb0240","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.27650","article-title":"IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells","volume":"11","author":"Mansor","year":"2020","journal-title":"Oncotarget"},{"issue":"28","key":"10.1016\/j.bbcan.2026.189672_bb0245","doi-asserted-by":"crossref","first-page":"25897","DOI":"10.18632\/oncotarget.4532","article-title":"IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma","volume":"6","author":"Myers","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0250","first-page":"2559","article-title":"IGFBP2 promotes the EMT of colorectal cancer cells by regulating E-cadherin expression","volume":"12","author":"Zhu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"13","key":"10.1016\/j.bbcan.2026.189672_bb0255","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.1002\/cam4.6071","article-title":"Insulin-like growth factor binding protein-2 and glucose-regulated protein 78kDa: Potential biomarkers affect prognosis in IDH-wildtype glioblastoma patients","volume":"12","author":"Harland","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189672_bb0260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2020.12.008","article-title":"IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway","volume":"500","author":"Sun","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189672_bb0265","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.2147\/JIR.S483705","article-title":"Identification of cellular senescence-related critical genes and molecular classification and revealing the drug-resistant therapeutic effect of IGFBP2 in chronic myeloid leukemia","volume":"17","author":"Xu","year":"2024","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13027-023-00543-6","article-title":"IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt\/\u03b2-catenin pathway","volume":"18","author":"Chen","year":"2023","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189672_bb0275","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/onc.2015.131","article-title":"IGFBP2 potentiates nuclear EGFR-STAT3 signaling","volume":"35","author":"Chua","year":"2016","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189672_bb0280","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1210\/endo.137.11.8895319","article-title":"Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix","volume":"137","author":"Arai","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2026.189672_bb0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2015.00025","article-title":"IGF-binding protein 2 - oncogene or tumor suppressor?","volume":"6","author":"Pickard","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.bbcan.2026.189672_bb0290","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/en.2011-1121","article-title":"IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells","volume":"152","author":"Azar","year":"2011","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0295","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"Baxter","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0300","first-page":"115","article-title":"Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions","volume":"1","author":"Degraff","year":"2009","journal-title":"Am. J. Transl. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0305","article-title":"Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) promotes castration-resistant prostate cancer progression by regulating AR-V7 mRNA stability","volume":"8","author":"Saini","year":"2025","journal-title":"Cancer Rep (Hoboken)"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189672_bb0310","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41419-024-06843-y","article-title":"IGFBP2\/ITGA5 promotes gefitinib resistance via activating STAT3\/CXCL1 axis in non-small cell lung cancer","volume":"15","author":"Lu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0315","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jcp.2004.020834","article-title":"Significant expression of IGFBP2 in breast cancer compared with benign lesions","volume":"58","author":"Busund","year":"2005","journal-title":"J. Clin. Pathol."},{"issue":"50","key":"10.1016\/j.bbcan.2026.189672_bb0320","doi-asserted-by":"crossref","first-page":"50422","DOI":"10.1074\/jbc.M306894200","article-title":"Insulin-like growth factor-II regulates PTEN expression in the mammary gland","volume":"278","author":"Moorehead","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0325","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1210\/en.2012-1970","article-title":"Insulin-like growth Factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor","volume":"154","author":"Foulstone","year":"2013","journal-title":"Endocrinology"},{"issue":"40","key":"10.1016\/j.bbcan.2026.189672_bb0330","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/sj.onc.1210397","article-title":"IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells","volume":"26","author":"Perks","year":"2007","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189672_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16112113","article-title":"The role of Insulin-like Growth Factor Binding Protein (IGFBP)-2 in DNA repair and chemoresistance in breast cancer cells","volume":"16","author":"Mohammedali","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0340","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1349-7006.2007.00448.x","article-title":"Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix","volume":"98","author":"Miyamoto","year":"2007","journal-title":"Cancer Sci."},{"issue":"6024","key":"10.1016\/j.bbcan.2026.189672_bb0345","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","article-title":"A perspective on cancer cell metastasis","volume":"331","author":"Chaffer","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0350","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12964-023-01264-4","article-title":"Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.bbcan.2026.189672_bb0355","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1158\/2767-9764.CRC-23-0176","article-title":"Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis","volume":"4","author":"Alicea","year":"2024","journal-title":"Cancer Res Commun"},{"issue":"20","key":"10.1016\/j.bbcan.2026.189672_bb0360","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1074\/jbc.M513686200","article-title":"An interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and integrin α5 is essential for IGFBP2-induced cell mobility *","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0365","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.leukres.2011.08.006","article-title":"High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia","volume":"35","author":"K\u00fchnl","year":"2011","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0370","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1756-8722-6-72","article-title":"IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells","volume":"6","author":"Chen","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0375","doi-asserted-by":"crossref","first-page":"21527","DOI":"10.1038\/s41598-021-01127-3","article-title":"Anticancer properties of dried-pericarp water extracts of Camellia japonica L. fermented with Aspergillus oryzae through regulation of IGFBP-2\/mTOR pathway","volume":"11","author":"Cho","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47070478","article-title":"IGFBP2 modulates trophoblast function and epithelial-mesenchymal transition in preeclampsia via the PI3K\/AKT signaling pathway","volume":"47","author":"Meng","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0385","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1158\/1535-7163.MCT-13-0233","article-title":"IGFBP2\/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells","volume":"12","author":"Lu","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189672_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12101625","article-title":"Glioblastoma-specific strategies of vascularization: implications in anti-angiogenic therapy resistance","volume":"12","author":"Buccarelli","year":"2022","journal-title":"J Pers Med"},{"issue":"22","key":"10.1016\/j.bbcan.2026.189672_bb0395","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1158\/0008-5472.CAN-16-0438","article-title":"IGFBP2 activates the NF-\u03baB pathway to drive epithelial-mesenchymal transition and invasive character in pancreatic ductal adenocarcinoma","volume":"76","author":"Gao","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189672_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061899","article-title":"Cancer-associated fibroblasts: master tumor microenvironment modifiers","volume":"15","author":"Wright","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0405","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/mr-2021-0028","article-title":"Extracellular matrix in cancer progression and therapy","volume":"2","author":"He","year":"2022","journal-title":"Med Rev (2021)"},{"key":"10.1016\/j.bbcan.2026.189672_bb0410","doi-asserted-by":"crossref","first-page":"1582532","DOI":"10.3389\/fimmu.2025.1582532","article-title":"Revisiting the role of cancer-associated fibroblasts in tumor microenvironment","volume":"16","author":"Lan","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0415","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0420","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-020-00341-1","article-title":"Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer","volume":"5","author":"Bulle","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"37","key":"10.1016\/j.bbcan.2026.189672_bb0425","doi-asserted-by":"crossref","first-page":"61674","DOI":"10.18632\/oncotarget.18669","article-title":"Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189672_bb0430","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s11262-025-02178-8","article-title":"IGFBP2 up-regulation by EBV via TGF-\u03b2 signaling: a key mechanism in nasopharyngeal carcinoma progression","volume":"61","author":"Lv","year":"2025","journal-title":"Virus Genes"},{"key":"10.1016\/j.bbcan.2026.189672_bb0435","article-title":"IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"28","key":"10.1016\/j.bbcan.2026.189672_bb0440","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4532","article-title":"IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma","volume":"6","author":"Myers","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: A strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189672_bb0450","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.2147\/OTT.S249527","article-title":"Insulin-like growth factor binding protein-2 promotes proliferation and predicts poor prognosis in hepatocellular carcinoma","volume":"13","author":"Ma","year":"2020","journal-title":"Onco. Targets Ther."},{"issue":"26","key":"10.1016\/j.bbcan.2026.189672_bb0455","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/s41388-021-01865-8","article-title":"COL11A1 activates cancer-associated fibroblasts by modulating TGF-\u03b23 through the NF-\u03baB\/IGFBP2 axis in ovarian cancer cells","volume":"40","author":"Wu","year":"2021","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0460","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/biom10121666","article-title":"Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts","volume":"10","author":"Shi","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0465","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189672_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212195","article-title":"Insulin-like Growth Factor Binding Protein-2 (IGFBP2) is a key molecule in the MACC1-mediated platelet communication and metastasis of colorectal cancer cells","volume":"22","author":"Haschemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189672_bb0475","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57243","article-title":"Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy","volume":"9","author":"Barrett","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.bbcan.2026.189672_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215737","article-title":"Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression","volume":"540","author":"Walterskirchen","year":"2022","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0485","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/med.21473","article-title":"The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: autophagy plays a role","volume":"38","author":"Thuwajit","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010149","article-title":"Fibronectin and periostin as prognostic markers in ovarian cancer","volume":"9","author":"Kujawa","year":"2020","journal-title":"Cells"},{"issue":"47","key":"10.1016\/j.bbcan.2026.189672_bb0495","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1038\/s41388-023-02844-x","article-title":"Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine","volume":"42","author":"Xin","year":"2023","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.bbcan.2026.189672_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147575","article-title":"TGF-\u03b2 signaling: from tissue fibrosis to tumor microenvironment","volume":"22","author":"Chung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189672_bb0505","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fendo.2019.00822","article-title":"IGFBP-2 signaling in the brain: from brain development to higher order brain functions","volume":"10","author":"Khan","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0510","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2004.01.039","article-title":"Involvement of insulin-like growth factor binding protein-2 in activated microglia as assessed in post mortem human brain","volume":"362","author":"Chesik","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0515","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2024.02.042","article-title":"It took a long, long time: Ras and the race to cure cancer","volume":"187","author":"Weinberg","year":"2024","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189672_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12122005","article-title":"IGFBP2 drives regulatory T cell differentiation through STAT3\/IDO signaling pathway in pancreatic cancer","volume":"12","author":"Sun","year":"2022","journal-title":"J Pers Med"},{"issue":"13","key":"10.1016\/j.bbcan.2026.189672_bb0525","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1073\/pnas.0609139104","article-title":"Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K\/Akt pathway activation in glioblastoma and prostate cancer","volume":"104","author":"Mehrian-Shai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0530","first-page":"2140","article-title":"A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value","volume":"15","author":"Liu","year":"2023","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0535","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","article-title":"Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas","volume":"100","author":"Colomiere","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189672_bb0540","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189672_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222999","article-title":"IGFBP2 promotes immunosuppression associated with its mesenchymal induction and Fc\u03b3RIIB phosphorylation in glioblastoma","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0550","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1426516","article-title":"Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples","volume":"7","author":"Cai","year":"2018","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0555","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/cas.13567","article-title":"Cross-talk between ovarian cancer cells and macrophages through periostin promotes macrophage recruitment","volume":"109","author":"Tang","year":"2018","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0560","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12031-015-0589-3","article-title":"Insulin-like growth factor binding protein-2 promotes adhesion of endothelial progenitor cells to endothelial cells via integrin \u03b15\u03b21","volume":"57","author":"Feng","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"20","key":"10.1016\/j.bbcan.2026.189672_bb0565","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1074\/jbc.M513686200","article-title":"An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0570","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1210\/endrev\/bnad008","article-title":"Signaling pathways of the insulin-like growth factor binding proteins","volume":"44","author":"Baxter","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbcan.2026.189672_bb0575","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-12-1681","article-title":"MDA-9\/syntenin and IGFBP-2 promote angiogenesis in human melanoma","volume":"73","author":"Das","year":"2013","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189672_bb0580","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.1120375109","article-title":"Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-\u03baB network","volume":"109","author":"Holmes","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0585","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-4598-4-7","article-title":"Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion","volume":"4","author":"Lee","year":"2005","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0590","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/ijgc-00009577-200607000-00006","article-title":"High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels","volume":"16","author":"Lancaster","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0595","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1677\/jme.0.0320859","article-title":"Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells","volume":"32","author":"Sch\u00fctt","year":"2004","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0600","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.4734","article-title":"Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies","volume":"239","author":"Phillips","year":"2016","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0605","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2478\/s13380-011-0025-2","article-title":"IGFBP-2 expression, angiogenesis and pseudopalisades in glioblastoma","volume":"2","author":"Pa\u017eanin","year":"2011","journal-title":"Transl. Neurosci."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189672_bb0610","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41388-018-0525-4","article-title":"IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0615","first-page":"1857","article-title":"Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K\/AKT inhibition","volume":"34","author":"Chiablaem","year":"2014","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0620","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.yexmp.2015.08.009","article-title":"Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2\/Twist1 cooperation","volume":"99","author":"Liu","year":"2015","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189079","article-title":"VEGF signaling: role in angiogenesis and beyond","volume":"1879","author":"Shaw","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"50","key":"10.1016\/j.bbcan.2026.189672_bb0630","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106151","article-title":"IGFBP2 derived from PO-MSCs promote epithelial barrier destruction by activating FAK signaling in nasal polyps","volume":"26","author":"You","year":"2023","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0640","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000450681","article-title":"Genome-wide STAT3 binding analysis after histone deacetylase inhibition reveals novel target genes in dendritic cells","volume":"9","author":"Sun","year":"2017","journal-title":"J Innate Immun"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0645","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2353\/ajpath.2009.081004","article-title":"Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer","volume":"175","author":"Yazawa","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bbcan.2026.189672_bb0650","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0655","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/cas.16447","article-title":"IGFBP2 promotes proliferation and glycolysis of endometrial cancer by regulating PKM2\/HIF-1\u03b1 axis","volume":"116","author":"Jin","year":"2025","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0660","first-page":"C252","article-title":"Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization","volume":"326","author":"Zhang","year":"2024","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"16","key":"10.1016\/j.bbcan.2026.189672_bb0665","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/cam4.4680","article-title":"Prognostic value of IGFBP2 in various cancers: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2022","journal-title":"Cancer Med."},{"issue":"28","key":"10.1016\/j.bbcan.2026.189672_bb0670","doi-asserted-by":"crossref","first-page":"11736","DOI":"10.1073\/pnas.0703145104","article-title":"Insulin-like growth factor binding protein 2 promotes glioma development and progression","volume":"104","author":"Dunlap","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2026.189672_bb0675","doi-asserted-by":"crossref","first-page":"1814752","DOI":"10.3389\/fnut.2026.1814752","article-title":"Tissue-specific roles of IGFBP2 in glucose and lipid metabolism in obesity-related metabolic diseases","volume":"13","author":"Song","year":"2026","journal-title":"Front Nutr"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0680","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/brain\/awad398","article-title":"Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains","volume":"147","author":"Quesnel","year":"2024","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0685","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/jc.2007-2295","article-title":"Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population","volume":"93","author":"Martin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0690","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3233\/JAD-170263","article-title":"Peripheral versus central index of metabolic dysfunction and associations with clinical and pathological outcomes in Alzheimer's disease","volume":"60","author":"McLimans","year":"2017","journal-title":"J. Alzheimer's Dis"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0695","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/db18-0620","article-title":"Insulin-like Growth Factor Binding Protein 2 (IGFBP-2) and the risk of developing type 2 diabetes","volume":"68","author":"Wittenbecher","year":"2019","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0700","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1530\/EJE-16-0940","article-title":"The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage","volume":"176","author":"Hjortebjerg","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0705","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s43856-025-01213-x","article-title":"Proteomics-based clustering outperforms clinical clustering in identifying people with heart failure with distinct outcomes","volume":"5","author":"van Vugt","year":"2025","journal-title":"Commun. Med. (Lond.)"},{"key":"10.1016\/j.bbcan.2026.189672_bb0710","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-025-02712-6","article-title":"Targeted proteomic profiling of transcatheter edge-to-edge repair failure in patients with mitral regurgitation and heart failure","author":"Di Pasquale","year":"2025","journal-title":"Clin. Res. Cardiol."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189672_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158220","article-title":"Insulin-like Growth Factor-Binding Protein 2 in severe aortic valve stenosis and pulmonary hypertension: a gender-based perspective","volume":"25","author":"Boxhammer","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0720","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/pathophysiology31040045","article-title":"IGFBP-2 in critical illness: a prognostic marker in the growth hormone\/insulin-like growth factor axis","volume":"31","author":"Savvidis","year":"2024","journal-title":"Pathophysiology"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0725","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12859-023-05379-w","article-title":"Exploration of m(6)A methylation regulators as epigenetic targets for immunotherapy in advanced sepsis","volume":"24","author":"Qian","year":"2023","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.bbcan.2026.189672_bb0730","first-page":"1","article-title":"IGFBP2: integrative hub of developmental and oncogenic signaling network","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0735","doi-asserted-by":"crossref","first-page":"20230893","DOI":"10.1515\/med-2023-0893","article-title":"Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer","volume":"19","author":"Xu","year":"2024","journal-title":"Open Med (Wars)"},{"issue":"23","key":"10.1016\/j.bbcan.2026.189672_bb0740","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1158\/1078-0432.CCR-21-1579","article-title":"Immunization with a plasmid DNA vaccine encoding the N-terminus of insulin-like growth factor binding protein-2 in advanced ovarian Cancer LEADS to high-level type I immune responses","volume":"27","author":"Cecil","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189672_bb0745","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbrc.2010.05.145","article-title":"IGFBP2 promotes glioma tumor stem cell expansion and survival","volume":"397","author":"Hsieh","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189672_bb0750","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/bjc.2014.435","article-title":"Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin \u03b21-ERK pathway","volume":"111","author":"Han","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0755","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40478-023-01557-2","article-title":"IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma","volume":"11","author":"Kunhiraman","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189672_bb0760","first-page":"5072","article-title":"IGFBP2 induces SPRY1 expression via NF-\u03baB signaling pathway in glioblastoma multiforme (GBM)","volume":"21","author":"Yuan","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189672_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004169","article-title":"Simulation predicts IGFBP2-HIF1\u03b1 interaction drives glioblastoma growth","volume":"11","author":"Lin","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0770","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3803\/EnM.2017.32.1.11","article-title":"Recent insights into insulin-like growth factor binding protein 2 transcriptional regulation","volume":"32","author":"Shin","year":"2017","journal-title":"Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189672_bb0775","first-page":"1487","article-title":"Insulin-like growth factor binding protein-2 regulates \u03b2-catenin signaling pathway in glioma cells and contributes to poor patient prognosis","volume":"18","author":"Patil","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0780","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3324\/haematol.2022.280757","article-title":"RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia","volume":"108","author":"Zhang","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2026.189672_bb0785","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41388-025-03658-9","article-title":"IRF2BPL transcriptionally regulates IGFBP2 to promote tumor progression and suppresses immune cell infiltration in esophageal squamous cell carcinoma","volume":"45","author":"Wu","year":"2026","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0790","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.dld.2019.10.008","article-title":"IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-\u03baB signaling pathway","volume":"52","author":"Guo","year":"2020","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189672_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189312","article-title":"Tertiary lymphoid structures achieve 'cold' to 'hot' transition by remodeling the cold tumor microenvironment","volume":"1880","author":"Cui","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189672_bb0800","doi-asserted-by":"crossref","first-page":"1344272","DOI":"10.3389\/fimmu.2024.1344272","article-title":"Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189672_bb0805","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41375-022-01651-9","article-title":"Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia","volume":"36","author":"Feng","year":"2022","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189672_bb0810","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/187152010794728639","article-title":"Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation","volume":"10","author":"Mas-Moruno","year":"2010","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189672_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223768","article-title":"Enhancing tumor targeted therapy: the role of iRGD peptide in advanced drug delivery systems","volume":"16","author":"Nikitovic","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189672_bb0820","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.708779","article-title":"Roles of integrins in gastrointestinal cancer metastasis","volume":"8","author":"Hou","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189672_bb0825","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41419-026-08430-9","article-title":"Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma","volume":"17","author":"Qi","year":"2026","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189672_bb0830","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cac2.12420","article-title":"High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway","volume":"43","author":"Wen","year":"2023","journal-title":"Cancer Commun. (Lond.)"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:21:00Z","timestamp":1789518060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":166,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001447"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189672","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rewiring the tumor microenvironment: IGFBP2 at the Nexus of remodeling and therapy resistance?","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189672"}}